22 Grants
2021
Development of dmPGE2 and Bcl-xl-targeting senolytics as medical countermeasures for H-ARS and DEARE
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5U19AI150574-02-6501), $234,743USD, 2020-06-16 -- 2025-05-31
 
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5U01AI138283-04), $507,999USD, 2018-03-08 -- 2023-02-28
2020
Age-Related Differences in Response to Radiation and Medical Countermeasures
ORSCHELL, CHRISTIE M and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5UH3AI128894-05), $131,435USD, 2016-09-23 -- 2021-08-31
 
Development of dmPGE2 and Bcl-xl-targeting senolytics as medical countermeasures for H-ARS and DEARE
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1U19AI150574-01-6501), $251,375USD, 2020
 
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5U01AI138283-03), $518,282USD, 2018-03-08 -- 2023-02-28
2019
Age-Related Differences in Response to Radiation and Medical Countermeasures
ORSCHELL, CHRISTIE M and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5UH3AI128894-04), $148,496USD, 09/23/2016 -- 08/31/2021
 
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5U01AI138283-02), $528,096USD, 03/08/2018 -- 02/28/2023
2018
Age-Related Differences in Response to Radiation and Medical Countermeasures
ORSCHELL, CHRISTIE M and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 4UH3AI128894-03), $170,069USD, 09/23/2016 -- 08/31/2021
 
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1U01AI138283-01), $528,607USD, 03/08/2018 -- 02/28/2023
2017
Age-Related Differences in Response to Radiation and Medical Countermeasures
ORSCHELL, CHRISTIE M and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5UH2AI128894-02), $97,541USD, 09/23/2016 -- 08/31/2021
 
Long-acting growth factors for treating the acute and long term effects of lethal
COX, GEORGE N and ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5U01AI107340-05), $476,768USD, 05/15/2013 -- 04/30/2018
2016
Age-Related Differences in Response to Radiation and Medical Countermeasures
ORSCHELL, CHRISTIE M and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1UH2AI128894-01), $52,081USD, 09/23/2016 -- 08/31/2021
 
Long-acting growth factors for treating the acute and long term effects of lethal
COX, GEORGE N and ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 4U01AI107340-04), $674,036USD, 05/15/2013 -- 04/30/2018
2015
Long-acting growth factors for treating the acute and long term effects of lethal
COX, GEORGE N and ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5U01AI107340-03), $553,403USD, 05/15/2013 -- 04/30/2016
2014
Long-acting growth factors for treating the acute and long term effects of lethal
COX, GEORGE N and ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5U01AI107340-02), $731,319USD, 05/15/2013 -- 04/30/2018
2013
Long-acting growth factors for treating the acute and long term effects of lethal
COX, GEORGE N and ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1U01AI107340-01), $488,794USD, 05/15/2013 -- 04/30/2018
2010
BioPlex 200 System with High Throughput Fluidics (HTF) Multiplex Array System
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 1S10RR026726-01), $84,372USD, 03/25/2010 -- 03/24/2011
2009
Multifaceted Interventions to Amplify HSC Engraftment
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL075660-05), $359,123USD, 04/01/2005 -- 03/31/2012
2008
Multifaceted Interventions to Amplify HSC Engraftment
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL075660-04), $359,123USD, 04/01/2005 -- 03/31/2010
2007
Multifaceted Interventions to Amplify HSC Engraftment
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL075660-03), $359,123USD, 04/01/2005 -- 03/31/2010
2006
Multifaceted Interventions to Amplify HSC Engraftment
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL075660-02), $369,849USD, 04/01/2005 -- 03/31/2010
2005
Multifaceted Interventions to Amplify HSC Engraftment
ORSCHELL, CHRISTIE M
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL075660-01A2), $378,750USD, 04/01/2005 -- 03/31/2009